-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WD6GcGqlapDMT3nZEf6iYREY4NZwSiS3BEXHYb2Sp8fQlbrvLrEkVWJEm0KesyRE a2KApS4RrEL5L+Wvb84K9w== 0000904454-10-000017.txt : 20100119 0000904454-10-000017.hdr.sgml : 20100118 20100119161422 ACCESSION NUMBER: 0000904454-10-000017 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100119 DATE AS OF CHANGE: 20100119 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Transcept Pharmaceuticals Inc CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81821 FILM NUMBER: 10533457 BUSINESS ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: (510) 215-3500 MAIL ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DOMAIN PARTNERS V LP CENTRAL INDEX KEY: 0001207785 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 BUSINESS PHONE: 6096835656 MAIL ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 SC 13G/A 1 s13ga_011910-transcept.htm SCHEDULE 13G/A

CUSIP No. 89354M 10 6

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

(Amendment No. 2)1

 

 

Transcept Pharmaceuticals, Inc. (formerly Novacea, Inc.)

(Name of Issuer)

 

Common Stock, $.001 par value

(Title of Class of Securities)

 

89354M 10 6

(CUSIP Number)

 

December 31, 2009

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

 

o

Rule 13d-1(b)

 

o

Rule 13d-1(c)

 

x

Rule 13d-1(d)

 

 

 

_______________________

 

1The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 


CUSIP No. 89354M 10 6

 

1)

Name of Reporting Person

I.R.S. Identification

No. of Above Person

(Entities Only)

Domain Partners V, L.P.

2)

Check the Appropriate Box

if a Member of a Group

(a) x

(b) o

3)

SEC Use Only

 

4)

Citizenship or Place

of Organization

Delaware

Number of

Shares Beneficially

Owned by Each

Reporting Person

With

5)

Sole Voting
Power

-0-

6)

Shared Voting
Power

 

-0-

7)

Sole Dispositive
Power

-0-

8)

Shared Dispositive Power

 

-0-

9)

Aggregate Amount Beneficially Owned by Each Reporting Person

-0-

10)

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

11)

Percent of Class Represented by Amount in Row (9)

-0-

12)

Type of Reporting Person

PN

 

 


CUSIP No. 89354M 10 6

 

1)

Name of Reporting Person

I.R.S. Identification

No. of Above Person

(Entities Only)

DP V Associates, L.P.

2)

Check the Appropriate Box

if a Member of a Group

(a) x

(b) o

3)

SEC Use Only

 

4)

Citizenship or Place

of Organization

Delaware

Number of

Shares Beneficially

Owned by Each

Reporting Person

With

5)

Sole Voting
Power

-0-

6)

Shared Voting
Power

 

-0-

7)

Sole Dispositive
Power

-0-

8)

Shared Dispositive Power

 

-0-

9)

Aggregate Amount Beneficially Owned by Each Reporting Person

-0-

10)

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

11)

Percent of Class Represented by Amount in Row (9)

-0-

12)

Type of Reporting Person

PN

 

 


CUSIP No. 89354M 10 6

 

1)

Name of Reporting Person

I.R.S. Identification

No. of Above Person

(Entities Only)

Domain Associates, L.L.C.

2)

Check the Appropriate Box

if a Member of a Group

(a) x

(b) o

3)

SEC Use Only

 

4)

Citizenship or Place

of Organization

Delaware

Number of

Shares Beneficially

Owned by Each

Reporting Person

With

5)

Sole Voting
Power

-0-

6)

Shared Voting
Power

 

-0-

7)

Sole Dispositive
Power

-0-

8)

Shared Dispositive Power

 

-0-

9)

Aggregate Amount Beneficially Owned by Each Reporting Person

-0-

10)

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

11)

Percent of Class Represented by Amount in Row (9)

-0-

12)

Type of Reporting Person

OO

 

 


CUSIP No. 89354M 10 6

 

Amendment No. 2 to Schedule 13G (Final Amendment)

 

Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission on February 14, 2007 and Amendment No. 1 thereto filed on February 7, 2009 (as so amended, the “Schedule 13G”). Terms defined in the Schedule 13G are used herein as so defined.

 

The following Items of the Schedule 13G are hereby amended and restated as follows:

 

Item 1(a)

Name of Issuer: Transcept Pharmaceuticals, Inc. (formerly Novacea, Inc.)

 

Item 1(b)

Address of Issuer’s Principal Executive Offices:

 

 

1003 W. Cutting Blvd., Suite 110

 

South San Francisco, CA 94080

 

Item 4

Ownership.

 

 

(a)

Amount Beneficially Owned:

 

 

Domain V: -0-

 

DP V A: -0-

 

DA: -0-

 

 

(b)

Percent of Class:

 

 

Domain V: -0-

 

DP V A: -0-

 

DA: -0-

 

 

(c)

Number of shares as to which such person has:

 

 

(i)

sole power to vote or to direct the vote:

 

 

Domain V: -0-

 

DP V A: -0-

 

DA: -0-

 

 

(ii)

shared power to vote or to direct the vote: -0-

 

 

(iii)

sole power to dispose or to direct the disposition of:

 

 


CUSIP No. 89354M 10 6

 

 

Domain V: -0-

 

DP V A: -0-

 

DA: -0-

 

 

(iv)

shared power to dispose or to direct the disposition of: -0-

 

Item 5 -

Ownership Of Five Percent Or Less Of A Class.

 

If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the Common Stock, check the following: x

 


CUSIP No. 89354M 10 6

 

 

Signature:

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

DOMAIN PARTNERS V, L.P.

 

By:

One Palmer Square Associates

V, L.L.C., General Partner

 

 

By:

/s/ Kathleen K. Schoemaker

 

 

Managing Member

 

DP V ASSOCIATES, L.P.

 

By:

One Palmer Square Associates

V, L.L.C., General Partner

 

 

By:

/s/ Kathleen K. Schoemaker

 

 

Managing Member

 

DOMAIN ASSOCIATES, L.L.C.

 

By:

/s/ Kathleen K. Schoemaker

 

 

Managing Member

 

Date: January 19, 2010

 

 

 

-----END PRIVACY-ENHANCED MESSAGE-----